CellabMED
- Biotech or pharma, therapeutic R&D
CellabMED is a clinical-stage biotech company dedicated to advancing innovative anti-cancer therapies based on a proprietary Chimeric Antigen Receptor T cell (CAR-T) platform and monoclonal antibody (mAb).We currently have two clinical-stage programs and additional preclinical assets in our pipeline.
In addition to its internal R&D programs, CellabMED operates a GMP-certified facility for CAR-T manufacturing, offering flexible CDMO services to support external partners from early development through clinical-stage production.
We are also open to licensing out or co-development opportunities for our assets to advance them through strategic collaborations.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}